KRAS and colorectal cancer: Recently, it was found that patient survival in colorectal cancer is influenced by different molecular subtypes, including not only Kras mutation status, but several other genetic and epigenetic factors.[34] Because molecular subtype was not determined in the CAIRO2 population, we cannot completely exclude an effect of molecular subtype on the outcome of our analyses.